Showing results (1111-1120 of 1,171) with videos related to

Sort By:
Pageof 118
Signal Transduction and Targeted Therapy|March 17, 2023
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 studyGuo-Ming Shi, Xiao-Yong Huang, Dong Wu, et al.
Frontiers in Immunology|September 16, 2021
CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic CholangiocarcinomaXiao-Jun Guo, Jia-Cheng Lu, Hai-Ying Zeng, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 12, 2024
Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migrationChen-Yang Tao, Xiao-Ling Wu, Shu-Shu Song, et al.
Chinese Medical Journal|November 15, 2017
Shanghai Score: A Prognostic and Adjuvant Treatment-evaluating System Constructed for Chinese Patients with Hepatocellular Carcinoma after Curative ResectionHui-Chuan Sun, Lu Xie, Xin-Rong Yang, et al.
Ebiomedicine|April 26, 2023
Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SW-BIC-213, as a heterologous booster in healthy adults: an open-labeled, two-centered and multi-arm randomised, phase 1 trialYu-Zhou Gui, Xue-Ning Li, Jing-Xin Li, et al.
The Lancet. Oncology|May 11, 2025
Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trialJian Zhou, Li Bai, Jia Luo, et al.
Communications Biology|November 21, 2023
Single-cell and spatial architecture of primary liver cancerPei-Yun Zhou, Cheng Zhou, Wei Gan, et al.
Cell Research|August 5, 2024
SMYD5 is a ribosomal methyltransferase that catalyzes RPL40 lysine methylation to enhance translation output and promote hepatocellular carcinomaBisi Miao, Ling Ge, Chenxi He, et al.
The New England Journal of Medicine|January 17, 2024
Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19Bin Cao, Yeming Wang, Hongzhou Lu, et al.
Gastroenterology|February 8, 2014
Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patientsQiang Gao, Ying-Jun Zhao, Xiao-Ying Wang, et al.
Pageof 118